Central Finland Hospital District Central Finland Hospital Nova — Clinical Trial Site

16 Registered trials

9 Currently recruiting

Organisation

Central Finland Hospital District Central Finland Hospital Nova

Location

Jyvaskyla, Finland

Identifier

ORG-100043830

Address

Hoitajantie 3, 40620, Finland

Departments

Abdominal Center - Urology
Central Finland Hospital District
Department of Obstetrics and Gynecology
Department of Orthopaedics, traumatolofy and hand surgery
Department of Urology
Heart Center
Keski-Suomen Keskussairaala Loc. 13
N/A
Oncology
Pediatric Neurology
rtment of Anesthesiology and Intensive Care
Surgery
Syöpätautien klinikka
Syövänhoito
Urology

Clinical trials at this site (16)

Search interface

The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility Not authorised

2022-500792-31-00 Endometriosis in women with involuntary infertility 6
Optimizing the antibiotic treatment of uncomplicated acute appendicitis - APPAC II Pending

2024-518984-36-00 Uncomplicated acute appendicitis 6
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Acute critical illness requiring intensive care unit ad 6 2025-06-26
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn (INCAR… Recruiting

2024-512084-31-00 Patients requiring emergency abdominal or body CT with 6 2025-06-24
RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer… Recruiting

2024-520288-15-00 Metastatic or locally advanced inoperable colorectal ca 6 2025-01-25
Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTR… Recruiting

2023-504704-28-00 Prostate cancer 4 2024-09-01
Avoiding Risks of Thrombosis and bleeding in Surgery (ARTS) trial Recruiting

2023-508147-43-00 Venous thromboembolism (in surgical patients) 6 2024-05-31
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE) Recruiting

2023-504340-34-01 Coronary artery disease 6 2024-01-11
Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy Recruiting

2024-517854-91-00 Metastatic or high-risk recurrent prostate cancer manag 5 2019-08-05
Prediction and prevention of infantile spasms in high risk children Recruiting

2024-517488-22-00 Patients in high risk for infantile spasm syndrome (age 6 2018-05-28
An open study for participants who have been on darolutamide treatment in any other Bayer study Ended

2022-502084-38-00 Cancer 5 2020-10-16
DupuytrEn Treatment EffeCtiveness Trial (DETECT) Ended

2024-515110-40-00 Dupuytren's contracture 5 2017-09-15
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
Long Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis. Ended

2023-505699-31-00 Ulcerative Colitis 5 2017-01-02
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3… Ended

2022-501251-81-00 Renal cell carcinoma 5 2017-06-08